Short-Term Effectiveness and Safety of Haart in the Form of a Generic Fixed-Dose Combination of Stavudine, Lamivudine and Nevirapine (Triviro) in Hiv-1-Infected Adults in Zimbabwe (Clinical‪)‬

The success of HIV/AIDS treatment depends on the effective and appropriate use of antiretroviral agents (ARVs). Resource-limited countries bear the brunt of this public health crisis, and their responses necessarily differ from those of industrialised nations. Ideally, ARV administration and patient monitoring in public programmes should be standardised, with free, effective, tolerable drugs and simple regimens to promote patient compliance. Most developing countries employ the World Health Organization (WHO) public health approach to antiretroviral treatment, which aims to maximise patient survival using highly active antiretroviral therapy (HAART) with a combination of three agents from different drug classes in order to enhance efficacy and minimise the development of resistance through the promotion of adherence. (1)